Targeting the IL-17 pathway in inflammatory disorders

Cong-Qiu Chu

Research output: Book/ReportBook

Abstract

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

Original languageEnglish (US)
PublisherSpringer International Publishing
Number of pages102
ISBN (Electronic)9783319280400
ISBN (Print)9783319280394
DOIs
StatePublished - Jan 1 2016

Fingerprint

Interleukin-17
Inflammation
Autoimmunity
Consumer Product Safety
Psoriatic Arthritis
Ankylosing Spondylitis
Allergy and Immunology
Inflammatory Bowel Diseases
Psoriasis
Multiple Sclerosis
Rheumatoid Arthritis
Cytokines
Therapeutics
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Targeting the IL-17 pathway in inflammatory disorders. / Chu, Cong-Qiu.

Springer International Publishing, 2016. 102 p.

Research output: Book/ReportBook

Chu, Cong-Qiu. / Targeting the IL-17 pathway in inflammatory disorders. Springer International Publishing, 2016. 102 p.
@book{85f407707f7645b7a03c04c4567cf497,
title = "Targeting the IL-17 pathway in inflammatory disorders",
abstract = "This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.",
author = "Cong-Qiu Chu",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-28040-0",
language = "English (US)",
isbn = "9783319280394",
publisher = "Springer International Publishing",

}

TY - BOOK

T1 - Targeting the IL-17 pathway in inflammatory disorders

AU - Chu, Cong-Qiu

PY - 2016/1/1

Y1 - 2016/1/1

N2 - This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

AB - This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

UR - http://www.scopus.com/inward/record.url?scp=85018861510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018861510&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-28040-0

DO - 10.1007/978-3-319-28040-0

M3 - Book

AN - SCOPUS:85018861510

SN - 9783319280394

BT - Targeting the IL-17 pathway in inflammatory disorders

PB - Springer International Publishing

ER -